Nuvation Bio Announces FDA Clearance to begin Clinical Trail of NUV-422 for Breast Cancer Treatment.
Summary – U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422. It is a…
Summary – U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-422. It is a…
SYNOPSIS: New 510(k) clearance expands the use of MammoScreen from 2D to 3D mammography, opening up the entire breast cancer screening market.…
SUMMARY: Impact Therapeutics is a biopharmaceutical company, announced that its ATR inhibitor IMP9064 has received the IND clearance from the US Food…